ArticleCancer chemotherapy and pharmacology2025
Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicity.
Rob Ter Heine et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.